Search Results - "de Faria, Fernanda Costas C"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors by Braggio, Danielle Almeida, Costas C de Faria, Fernanda, Koller, David, Jin, Feng, Zewdu, Abeba, Lopez, Gonzalo, Batte, Kara, Casadei, Lucia, Welliver, Meng, Horrigan, Stephen K, Han, Ruolan, Larson, Jeffrey L, Strohecker, Anne M, Pollock, Raphael E

    Published in PloS one (14-10-2022)
    “…Mutation in the CTNNB1 gene, leading to a deregulation of the WTN/β-catenin pathway, is a common feature of desmoid tumors (DTs). Many β-catenin inhibitors…”
    Get full text
    Journal Article
  2. 2

    Three dimensional models of dedifferentiated liposarcoma cell lines: scaffold-based and scaffold-free approaches by Tahara, Sayumi, de Faria, Fernanda Costas C., Sarchet, Patricia, Calore, Federica, Sharick, Joe, Leight, Jennifer L., Casadei, Lucia, Pollock, Raphael E.

    “…Sarcomas are rare malignancies, the number of reports is limited, and this rarity makes further research difficult even though liposarcoma is one of major…”
    Get full text
    Journal Article
  3. 3

    NFκB pathway and microRNA-9 and -21 are involved in sensitivity to the pterocarpanquinone LQB-118 in different CML cell lines by de Faria, Fernanda Costas C, Leal, Maria Eduarda Bento, Bernardo, Paula Sabbo, Costa, Paulo R R, Maia, Raquel C

    Published in Anti-cancer agents in medicinal chemistry (01-01-2015)
    “…Chronic myeloid leukemia (CML), a myeloproliferative disorder characterized by the BCR-ABL oncoprotein, presents its treatment based on tyrosine kinase…”
    Get more information
    Journal Article
  4. 4
  5. 5

    LQB‑118 compound inhibits migration and induces cell death in glioblastoma cells by Bernardo, Paula Sabbo, Guimarães, Gustavo Henrique C, De Faria, Fernanda Costas C, Longo, Gabriel M Da Cunha, Lopes, Giselle P De Faria, Netto, Chaquip Daher, Costa, Paulo R R, Maia, Raquel C

    Published in Oncology reports (01-01-2020)
    “…Glioblastoma (GBM) is the most frequent malignant brain tumor. It represents the most aggressive astrocytoma with an overall survival of 14 months. Despite…”
    Get full text
    Journal Article
  6. 6

    In situ hybridization to detect DNA amplification in extracellular vesicles by Casadei, Lucia, Sarchet, Patricia, Faria, Fernanda Costas C., Calore, Federica, Nigita, Giovanni, Tahara, Sayumi, Cascione, Luciano, Wabitsch, Martin, Hornicek, Francis J., Grignol, Valerie, Croce, Carlo M., Pollock, Raphael E.

    Published in Journal of extracellular vesicles (01-09-2022)
    “…EVs have emerged as an important component in tumour initiation, progression and metastasis. Although notable progresses have been made, the detection of EV…”
    Get full text
    Journal Article
  7. 7

    Preclinical efficacy of the Wnt/[beta]-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors by Braggio, Danielle Almeida, Costas C. de Faria, Fernanda, Koller, David, Jin, Feng, Zewdu, Abeba, Lopez, Gonzalo, Batte, Kara, Casadei, Lucia, Welliver, Meng, Horrigan, Stephen K, Han, Ruolan, Larson, Jeffrey L, Strohecker, Anne M, Pollock, Raphael E

    Published in PloS one (14-10-2022)
    “…Mutation in the CTNNB1 gene, leading to a deregulation of the WTN/[beta]-catenin pathway, is a common feature of desmoid tumors (DTs). Many [beta]-catenin…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors by Danielle Almeida Braggio, Fernanda Costas C. de Faria, David Koller, Feng Jin, Abeba Zewdu, Gonzalo Lopez, Kara Batte, Lucia Casadei, Meng Welliver, Stephen K. Horrigan, Ruolan Han, Jeffrey L. Larson, Anne M. Strohecker, Raphael E. Pollock

    Published in PloS one (01-01-2022)
    “…Mutation in the CTNNB1 gene, leading to a deregulation of the WTN/β-catenin pathway, is a common feature of desmoid tumors (DTs). Many β-catenin inhibitors…”
    Get full text
    Journal Article